Literature DB >> 8353632

Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.

B Fritzell1, B Hammarberg, H Schiratzki, S Haglund, E Knutsson, A Mårtensson.   

Abstract

From a total of 43 adductor spasmodic patients over a 10-year period, 11 underwent resection of a portion of the recurrent laryngeal nerve on one side. The initial results were excellent but a varying degree of recurrence took place in 8 patients. In 4, a reoperation was done. At the final follow-up, 2-8 years after the primary operation, 4 patients were no longer suffering from spasmodic dysphonia, another 5 were better off than before surgery, and 1 remained unchanged. Only 1 was worse off. Electromyographic findings indicated that the recurrence of symptoms was due to regeneration of the nerve fibers.

Entities:  

Mesh:

Year:  1993        PMID: 8353632     DOI: 10.1016/s0892-1997(05)80348-0

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  3 in total

1.  Temporal specificity of abnormal neural oscillations during phonatory events in laryngeal dystonia.

Authors:  Hardik Kothare; Sarah Schneider; Danielle Mizuiri; Leighton Hinkley; Abhishek Bhutada; Kamalini Ranasinghe; Susanne Honma; Coleman Garrett; David Klein; Molly Naunheim; Katherine Yung; Steven Cheung; Clark Rosen; Mark Courey; Srikantan Nagarajan; John Houde
Journal:  Brain Commun       Date:  2022-02-11

Review 2.  Research priorities in spasmodic dysphonia.

Authors:  Christy L Ludlow; Charles H Adler; Gerald S Berke; Steven A Bielamowicz; Andrew Blitzer; Susan B Bressman; Mark Hallett; H A Jinnah; Uwe Juergens; Sandra B Martin; Joel S Perlmutter; Christine Sapienza; Andrew Singleton; Caroline M Tanner; Gayle E Woodson
Journal:  Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 3.497

Review 3.  Treatment for spasmodic dysphonia: limitations of current approaches.

Authors:  Christy L Ludlow
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 1.814

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.